Known variously as bioelectronics or electroceuticals, emerging therapies that use the electronics or electrical stimulation of the nervous system to treat chronic disease offer exciting potential for improved human health and wellbeing.
The need to reduce greenhouse gas emissions is driving innovation in the passenger vehicle industry, and the University of Melbourne is at the forefront of research efforts through its longstanding partnership with the Ford Motor Company.
The brain’s electrical conductivity creates a special place in medicine for electrical engineers. It has allowed them to open new frontiers, using implanted electronic devices to bypass damaged human sense organs and reconnect the brain to information about the external world.
The potential of miniature implants to deliver controlled doses of medicine over many months is expected to revolutionise health care and improve treatment for an increasingly wide range of conditions over the next decade.
Associate Professor Nicholas Hutchins is working with a team of international collaborators to develop anti-fouling strategies for ships.